Highlights AFT Pharmaceuticals Limited

Equities

AFT

NZAFTE0001S4

End-of-day quote New Zealand S.E. Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
2.9 ^NZD	-1.02%		-3.97%	-17.14%

01/05	AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV	MT
24/04	New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV	01/05	MT
AFT Pharmaceuticals, Massey Ventures, Gillies McIndoe Research Institute Partner to Develop Topical Scar Treatment	24/04	MT
AFT Pharmaceuticals Limited, Massey Ventures, Gilles Mcindoe Research Institute to Develop Scar Treatment	24/04	CI
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	04/03	MT
Aft Expands Its Co-Operation with Hikma Pharmaceuticals	04/03	CI
AFT Pharmaceuticals Boosts Operating Profit Guidance for Fiscal Year 2024	16/02	MT
AFT Pharmaceuticals Limited Updates Earnings Guidance for the Fiscal Year 2024	16/02	CI
AFT Pharmaceuticals' Licensee Launches Pain Relief Medication in US; Shares Rise 4%	07/02	MT
AFT Pharmaceuticals Ties Up with Belgian Firm to Develop Skin Medication	19/01	MT
Hyloris Pharmaceuticals SA Enters into Partnership with AFT Pharmaceuticals to Develop a Novel Mucoadhesive Film for the Treatment of Vulvar Lichen Sclerosus	18/01	CI
AFT Pharmaceuticals Ties Up with Hyloris to Develop Burning Mouth Syndrome Treatment Candidate	22/12	MT
AFT Pharmaceuticals Limited Enters into Partnership with Hyloris Pharmaceuticals	22/12	CI
AFT Pharmaceuticals Limited Reaffirms Earnings Guidance for the Fiscal Year 2024	23/11	CI
AFT Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2023	23/11	CI
AFT Pharmaceuticals Secures Clearance to Sell Antiseptic Ointment in China	21/11	MT
Hyloris Pharma wins US FDA approval for pain treatment	18/23/18	RE
AFT Pharmaceuticals Secures Australia, New Zealand License for Epilepsy Rescue Medication	21/23/21	MT
AFT Pharmaceuticals Launches e-Commerce Stores in US, Australia	11/23/11	MT
AFT Pharmaceuticals Limited Extends E-Commerce Presence into Amazon US	11/23/11	CI
AFT Pharmaceuticals' FY23 Profit Falls on Higher Selling Costs	22/23/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AFT Pharmaceuticals Limited

Equities

AFT

NZAFTE0001S4

Highlights

Filters